SCHEMBL6764415

SCHEMBL6764415

CCOC(=O)C1(C(=O)OCC)CCC2(NCCc3cc(OC)c(OC)cc32)C(C2=NCCc3cc(OC)c(OC)cc32)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 2/20 0.36
KDM4E B2RXH2 7/20 0.36
MAOA P21397 4/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.34
KMT2A Q03164 3/20 0.33
HSD17B10 Q99714 2/20 0.33
KCNK3 O14649 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6764416 1.00 RAD52 (0.36) RAD52KDM4EMAOAMAPTALDH1A1
SCHEMBL6757301 0.80 KCNK3 (0.37) RAD52KDM4EMAOAMAPTALDH1A1
SCHEMBL6757299 0.80 KCNK3 (0.37) RAD52KDM4EMAOAMAPTALDH1A1
SCHEMBL6760148 0.73 KMT2A (0.37) KDM4EALDH1A1GAAKMT2AKCNK3
SCHEMBL6757305 0.73 KDM4E (0.37) KDM4EMAOAMAPTALDH1A1KMT2A
SCHEMBL6764239 0.72 SMN1; SMN2 (0.43) KDM4EMAPTALDH1A1KMT2A
SCHEMBL6759721 0.65 OPRM1 (0.32) KDM4EMAPTALDH1A1KMT2AHSD17B10
Iodide SCHEMBL6764433 0.64 KCNK3 (0.36) KDM4EALDH1A1KMT2AKCNK3
SCHEMBL1202228 0.64 KDM4E (0.57) RAD52KDM4EMAOAMAPTALDH1A1
SCHEMBL6757334 0.62 KMT2A (0.49) MAPTALDH1A1KMT2AKCNK3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106635-A1 having small-conductance potassium channel (SK) blocking activity TANABE SEIYAKU CO., LTD. (JP) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106635-A1 having small-conductance potassium channel (SK) blocking activity KCNN1, KCNN2, KCNN3 RAD52 4526/4885KDM4E 1346/4885MAOA 2284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.